What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA has approved a generic version of lenacapavir (Yeztugo), the world's only twice-a-year shot to prevent HIV -- a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The nonprofit health systems officially combined on Sunday following approval from state regulators. Tacoma, Washington-based MultiCare will invest $700 million over the next decade in Samaritan’s…
Tomorrow, I’ll hop on a plane for what has become my favorite day of the year. On Thursday, we’re hosting our second-ever Endpoints Health Tech Day, with a virtual daytime ...
For the first time in 30 years, a child in New York died of measles, which comes amid outbreaks in 45 states and Washington, D.C., according to the Centers for Disease Control and Prevention. Dr.
Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world. U.S. regulators on Monday approved a generic version for sale in low-income countries.
Demand for lenacapavir is far outstripping supply in Uganda, other parts of Africa and all over the world. U.S. regulators on Monday approved a generic version for sale in low-income countries.
(MedPage Today) -- America is growing older, like it or not. And as this happens, we need to find ways to take better care of our older and oldest patients.
